UTHR: Prakiraan wutah bathi saben saham kanggo taun ngarep unither.com

Logo perusahaan publik United Therapeutics (UTHR)

The stable management of United Therapeutics (UTHR) skillfully balances current revenues with long-term developments in organ engineering. Martin Rothblatt ensures transparent patent protection and implements xenotransplantation. The profit growth rate model for the coming year confirms these successes, where the latest parameter is 20.70. This strategy allows the company to diversify its biotech portfolio by creating artificial organs to save critically ill patients.

United Therapeutics Corp (UTHR): Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 17.11.2026

Rincian analitis lan laporan data perusahaan United Therapeutics Corp (UTHR)

Pambiji fundamental perusahaan:UTHR, unither.com
Produk dadi United Therapeutics Corporation

Profit dynamics determine the market value of an asset through the expected return on equity. This indicator measures the percentage deviation of the projected profit for the coming year from current values, capturing analyst optimism. By monitoring changes in the consensus net income growth estimate, an investor assesses the risk of stock overvaluation. For United Therapeutics (UTHR), this trend depends directly on the commissioning of new sterile capacities and the scaling of drug production.

Analisis perusahaan pesaing

VRTX (Vertex) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep ALNY (Alnylam)|Prakiraan wutah bathi saben saham kanggo taun ngarep INSM (Insmed)|BMRN (BioMarin Pharmaceutical Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BridgeBio BBIO|Dinamika bathi saben saham sing diarepake ing taun ngarep BGM|Cogent Biosciences - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep XERS (Xeris Biopharma)|KROS: Prakiraan wutah bathi kanggo taun ngarep|Arcturus Therapeutics Inc (ARCT) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Eton Pharma|KMDA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep fulcrumtx.com (FULC)|Prakiraan wutah bathi saben saham kanggo taun ngarep Abeona Therapeutics Inc. ABEO|Prakiraan wutah bathi kanggo taun ngarep MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|PLRX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|APLT - Prakiraan wutah bathi kanggo taun ngarep|RNTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Gelteq Limited Inc (GELS)|Prakiraan wutah bathi saben saham kanggo taun ngarep AYTU|Prakiraan wutah bathi resik saben saham ing taun ngarep chemomab.com CMMB|Prakiraan wutah bathi saben saham kanggo taun ngarep SRXH (SRx Health Solutions Inc)|PLRZ - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|INZY - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep